0001127602-12-025529.txt : 20120831
0001127602-12-025529.hdr.sgml : 20120831
20120831174151
ACCESSION NUMBER: 0001127602-12-025529
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120830
FILED AS OF DATE: 20120831
DATE AS OF CHANGE: 20120831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INGRAM DOUGLAS S
CENTRAL INDEX KEY: 0001190644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10269
FILM NUMBER: 121069171
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALLERGAN INC
CENTRAL INDEX KEY: 0000850693
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 951622442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 7142464500
MAIL ADDRESS:
STREET 1: P.O. BOX 19534
CITY: IRVINE
STATE: CA
ZIP: 92713-9534
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-08-30
0000850693
ALLERGAN INC
AGN
0001190644
INGRAM DOUGLAS S
2525 DUPONT DRIVE
IRVINE
CA
92612
1
EVP and President, EAME
Common Stock
2012-08-30
4
M
0
100000
36.15
A
124183.419
D
Common Stock
2012-08-30
4
S
0
100000
85.7823
D
24183.419
D
Common Stock
2665.0971
I
By 401(k) Trust
Common Stock
3600.682
I
By Esop Trust
Employee Stock Option (Right to Buy)
36.15
2012-08-30
4
M
0
100000
0
D
2015-02-08
Common Stock
100000
0
D
Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.61 to $85.96, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
Shares allocated to reporting person's SIP account as of reporting date.
Shares allocated to the reporting person's ESOP account as of reporting date.
The option became exercisable in four equal annual installments beginning February 9, 2006.
/s/ Matthew J. Maletta, attorney-in-fact for Douglas S. Ingram
2012-08-31